Back to Search
Start Over
Favorable Outcome of COVID-19 Infection in a Pediatric Cancer Patient Receiving an Anti-PD-L1/Anti-CTLA-4 Combination
- Source :
- Journal of Pediatric Hematology/Oncology. 43:e1045-e1046
- Publication Year :
- 2021
- Publisher :
- Ovid Technologies (Wolters Kluwer Health), 2021.
- Subjects :
- Oncology
Male
medicine.medical_specialty
2019-20 coronavirus outbreak
Adolescent
Coronavirus disease 2019 (COVID-19)
Anti ctla 4
B7-H1 Antigen
Internal medicine
Neoplasms
Humans
Medicine
CTLA-4 Antigen
Favorable outcome
Immune Checkpoint Inhibitors
SARS-CoV-2
business.industry
Anti pd 1
COVID-19
Hematology
Prognosis
Pediatric cancer
Pediatrics, Perinatology and Child Health
Immunology
business
Subjects
Details
- ISSN :
- 10774114
- Volume :
- 43
- Database :
- OpenAIRE
- Journal :
- Journal of Pediatric Hematology/Oncology
- Accession number :
- edsair.doi.dedup.....e4df8b30dbd09169d756245f15aff711